|Mary Galinski, Ph.D.
Area of Research: Malaria
The EVC’s Malaria
Research Program was established by
Dr. Mary Galinski beginning at the time of the opening of the
vaccine center premises in 1999. This highly successful program
has grown rapidly in its first five years at the EVC. Dr. Galinski
and her colleagues have been known internationally for their
discoveries of several P. vivax and P. falciparum merozoite vaccine
candidates, basic studies of simian malaria models, and investigations
of the molecular mechanisms that underpin antigenic variation.
Dr. Galinski brought these major lines of research to Emory and
has since expanded her program to include pathogenesis, epidemiology
and vaccine testing components. She also facilitated the development
of the current broad-based multi-investigator malaria research
effort at the EVC.
Dr. Galinski is a Professor in
the Division of Infectious Diseases of the Department of Medicine
and the Department of Microbiology and Immunology in Emory University’s
School of Medicine, and also holds an appointment in the Hubert Department
of Global Health of the Rollins School of Public Health. Dr. Galinski earned her Ph.D.
from the Sackler Institute of Biomedical Sciences at New York
University School of Medicine, with an emphasis in molecular
parasitology. Before joining Emory in 1998, she was a member
of the faculty at NYU School of Medicine in the Department of
Medical and Molecular Parasitology.
In addition to her research
efforts, Dr. Galinski is an internationally recognized leader
in efforts to raise awareness of the enormity
of the malaria burden worldwide, and advocate for the increase
of expanded research resources, interdisciplinary collaborative
linkages, and the development and implementation of effective
solutions to this major global health problem. Dr. Galinski
has also emphasized the need to train the next generation of
experts, and has encouraged the participation of educators
and health leaders worldwide in this effort. Towards achieving
goals, Dr. Galinski founded the Malaria
Foundation International in 1992, with the mission to facilitate the
development and implementation of solutions to the health,
economic and social problems caused by malaria.